Clostridium difficile infection (CDI) is a significant complication of antibiotic therapy and may be life-threatening. Any patient diagnosed with CDI requires prompt assessment, severity scoring and treatment.
Local guidance on diagnosis and management of CDI (link only active if accessing via NHS network), including a severity assessment sheet for use in hospital, is provided on the Infection Prevention and Control site.
Intravenous vancomycin must not be used to treat CDI - it does not penetrate into the lumen of the bowel
For an overview of the treatment of Clostridium difficile infection (CDI) see below.
10 days
| Therapy | Notes |
|
Vancomycin oral 125mg 6 hourly |
IV Vancomycin cannot be used for treatment of CDI, as it does not penetrate into the lumen of the bowel. |
| Therapy | Notes |
|
Vancomycin oral up to 500mg 6 hourly OR Fidaxomicin* oral 200mg 12 hourly *Fidaxomicin is a protected antimicrobial |
IV Vancomycin cannot be used for treatment of CDI, as it does not penetrate into the lumen of the bowel. Patients who fail to improve after 7 days oral vancomycin or continue to deteriorate should be discussed with an infection specialist. |
| Therapy | Notes |
|
Vancomycin oral 500mg 6 hourly AND Metronidazole IV 500mg 8 hourly |
IV Vancomycin cannot be used for treatment of CDI, as it does not penetrate into the lumen of the bowel. Life-threatening CDI = any of the below attributable to CDI:
Patients with suspected life-threatening CDI should be referred for senior surgical review as a matter of urgency. |
| Therapy | Notes |
|
Fidaxomicin oral 200mg 12 hourly |
If initial treatment course incomplete, treat as 1st episode. |
Use first line treatment option (see above).
(Prescribing in acute care: A prescribing protocol for the antimicrobial agents recommended for treatment of C.Difficile infection is available on the Hospital Electronic Prescription, Monitoring and Administration (HEPMA) system. Search Protocols -> Clostridium difficile).